Showing results (151-160 of 559) with videos related to
Sort By:
Pageof 56
JAMA Cardiology|December 12, 2019
Initiation of Angiotensin-Neprilysin Inhibition After Acute Decompensated Heart Failure: Secondary Analysis of the Open-label Extension of the PIONEER-HF TrialAdam D DeVore, Eugene Braunwald, David A Morrow, et al.Journal of Thrombosis and Thrombolysis|September 30, 2006
Drug-induced thrombocytopenia and thrombosis: evidence from patients receiving an oral glycoprotein IIb/IIIa inhibitor in the Orbofiban in Patients with Unstable coronary Syndromes- (OPUS-TIMI 16) trialBenjamin M Scirica, Christopher P Cannon, Richard Cooper, et al.Journal of the American College of Cardiology|April 25, 2009
Efficacy of ranolazine in patients with chronic angina observations from the randomized, double-blind, placebo-controlled MERLIN-TIMI (Metabolic Efficiency With Ranolazine for Less Ischemia in Non-ST-Segment Elevation Acute Coronary Syndromes) 36 TrialSean R Wilson, Benjamin M Scirica, Eugene Braunwald, et al.Circulation|April 8, 2009
Evaluation of the glycometabolic effects of ranolazine in patients with and without diabetes mellitus in the MERLIN-TIMI 36 randomized controlled trialDavid A Morrow, Benjamin M Scirica, Bernard R Chaitman, et al.European Heart Journal|May 17, 2019
Cardiovascular biomarkers in patients with acute decompensated heart failure randomized to sacubitril-valsartan or enalapril in the PIONEER-HF trialDavid A Morrow, Eric J Velazquez, Adam D DeVore, et al.European Heart Journal|April 20, 2010
One-year outcomes after a strategy using enoxaparin vs. unfractionated heparin in patients undergoing fibrinolysis for ST-segment elevation myocardial infarction: 1-year results of the ExTRACT-TIMI 25 trialDavid A Morrow, Elliott M Antman, Keith A A Fox, et al.European Heart Journal|August 7, 2008
Reduction in recurrent cardiovascular events with prasugrel compared with clopidogrel in patients with acute coronary syndromes from the TRITON-TIMI 38 trialSabina A Murphy, Elliott M Antman, Stephen D Wiviott, et al.Journal of the American College of Cardiology|November 27, 2007
Serial measurement of monocyte chemoattractant protein-1 after acute coronary syndromes: results from the A to Z trialJames A de Lemos, David A Morrow, Michael A Blazing, et al.Journal of the American College of Cardiology|July 7, 2018
Fatal or Irreversible Bleeding and Ischemic Events With Rivaroxaban in Acute Coronary SyndromeC Michael Gibson, Bennett Levitan, William J Gibson, et al.The American Journal of Cardiology|October 10, 2002
Prognosis in the thrombolysis in myocardial ischemia III registry according to the Braunwald unstable angina pectoris classificationBenjamin M Scirica, Christopher P Cannon, Carolyn H McCabe, et al.Pageof 56